The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Rachlin Evan Lockwood

Reporting owner CIK 0002151678 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Rachlin Evan LockwoodRachlin Evan LockwoodRachlin Evan Lockwood · October 16, 2026 · Conversion · Common StockRachlin Evan Lockwood · October 16, 2026 · Purchase · Common StockRachlin Evan Lockwood · October 16, 2026 · Conversion · Common StockRachlin Evan Lockwood · October 16, 2026 · Conversion · Common StockRachlin Evan Lockwood · October 14, 2026 · Stock award · Stock Option (right to buy)Oct 14, 2026Oct 16, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 16, 2026Iambic Therapeutics, Inc.Common StockRachlin Evan LockwoodConversion
Oct 16, 2026Iambic Therapeutics, Inc.Common StockRachlin Evan LockwoodPurchase
Oct 16, 2026Iambic Therapeutics, Inc.Common StockRachlin Evan LockwoodConversion
Oct 16, 2026Iambic Therapeutics, Inc.Common StockRachlin Evan LockwoodConversion
Oct 14, 2026Iambic Therapeutics, Inc.Stock Option (right to buy)Rachlin Evan LockwoodStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Iambic Therapeutics, Inc.IAM · company listingsConversionCommon StockNon-derivative security · Code C57,754Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Iambic Therapeutics, Inc.IAM · company listingsPurchaseCommon StockNon-derivative security · Code P718,75016Value: 11,500,000Currency not specifiedView ↗
Trade: Iambic Therapeutics, Inc.IAM · company listingsConversionCommon StockNon-derivative security · Code C410,762Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Iambic Therapeutics, Inc.IAM · company listingsConversionCommon StockNon-derivative security · Code C1,458,736Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Iambic Therapeutics, Inc.IAM · company listingsStock awardStock Option (right to buy)Derivative security · Code A20,3000Value: 0Currency not specifiedView ↗